IFNG and cancer: Treatment with IFNγ significantly increased both membranous and total expression of MHC-I and PD-L1 in benign RWPE cells as well as DU-H, DU-L, PC3-H and PC3-L cancer cells (Fig. 1A, Figs. S3, S4, S5C and S6C).